pharmaceuticals

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and…

Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion.…

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite…

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decline in revenues for fiscal 2023. The…

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2024, reporting higher revenues…

Over the years, Johnson & Johnson (NYSE: JNJ) has constantly ramped up its portfolio and pipeline. After spinning off the…

Johnson & Johnson (NYSE: JNJ) reported first quarter 2024 earnings results today. Reported sales increased 2.3% year-over-year to $21.4 billion.…

After a slow start to the year, the IPO market is witnessing a rush of tech and healthcare companies seeking…

AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device…

Femasys Inc. (NASDAQ: FEMY) is a healthcare company that develops women's reproductive health solutions using state-of-the-art technology. The company’s portfolio…

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the second quarter of 2024. Net…

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the…

IPO activity gathered momentum this year in a sign that the market is recovering from the weakness experienced in 2023.…

Medical device maker CooperCompanies (NYSE: COO) announced financial results for the first quarter of 2024, reporting an increase in revenues…

Dentsply Sirona Inc. (NASDAQ: XRAY), a leading manufacturer of professional dental products and technologies, reported fourth-quarter 2023 financial results, reporting…

Healthcare company Agilent Technologies Inc. (NYSE: A) reported a decrease in adjusted earnings for the first quarter of 2024 when…

Biotechnology company Moderna, Inc. (NASDAQ: MRNA) reported a sharp decline in revenues and earnings for the fourth quarter of 2023.…

Pharmaceutical company Organon & Co. (NYSE: OGN) has reported higher revenues and adjusted earnings for the fourth quarter of 2023.…

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company that works with leading researchers and institutions to accelerate the development…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the fourth quarter of…